Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/69936, first published .
Prevalence of Frailty and Its Predictors Among Patients With Cancer at the Chemotherapy Stage: Systematic Review

Prevalence of Frailty and Its Predictors Among Patients With Cancer at the Chemotherapy Stage: Systematic Review

Prevalence of Frailty and Its Predictors Among Patients With Cancer at the Chemotherapy Stage: Systematic Review

Journals

  1. Hernández‐Aguiar Y, Becerra‐Bolaños Á, Rodríguez‐Pérez A. Frailty and Oncology: An Increasingly Common Combination. Cancer Medicine 2026;15(1) View
  2. Alkan A, Tanrıverdi Ö, Alkan A. Contextualizing frailty in ovarian cancer. Supportive Care in Cancer 2026;34(2) View
  3. Hu Y, Xie H, Hu Z, Luo D, Hu J, Huang F, Dong C. Symptom clusters and their association with frailty in older patients with lung cancer during chemotherapy: An analysis based on electronic nursing records. European Journal of Oncology Nursing 2026;80:103110 View
  4. Jin J, Zhong Z. Impact of pre-operative frailty on short-term outcomes of ovarian cancer: a systematic review and meta-analysis. Journal of Ovarian Research 2026 View